long intergenic non-protein coding RNA 2442Genealiases: []
Q-omics provides the consensus-scored LINC02442 profile across patient tissues and cancer cell-line models. LINC02442 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, LINC02442 is differentially expressed in 3, with the highest sampling consensus in THCA. Additionally, LINC02442 RNA expression shows 6,772 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KICH, THCA, and STAD as cancer lineages where LINC02442 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02442 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02442 survival associations across molecular data types. LINC02442 RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02442 RNA expression–survival associations across cancer types. High LINC02442 expression shows unfavorable associations in KICH, LUAD, READ, UCEC, ACC and THYM. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for LINC02442 RNA expression.
This table summarizes LINC02442 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02442. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02442 shows lower tumor expression in KICH and higher tumor expression in THCA and KIRP. The THCA box plot shows higher LINC02442 RNA expression in tumor versus normal tissue (log2 FC = +0.129, t-test p < 0.001).
This table shows molecular features associated with LINC02442 in patient tissues and cancer cell lines. In patient samples, LINC02442 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
